Molecular epidemiology of Saccharomyces cerevisiae in an immunocompromised host unit.

@article{Clemons2010MolecularEO,
  title={Molecular epidemiology of Saccharomyces cerevisiae in an immunocompromised host unit.},
  author={Karl V Clemons and Juha H. Salonen and Jouni Issakainen and Jukka Nikoskelainen and Michael Jefferson Mccullough and Jacks J. Jorge and David A Stevens},
  journal={Diagnostic microbiology and infectious disease},
  year={2010},
  volume={68 3},
  pages={
          220-7
        }
}
Saccharomyces cerevisiae is increasingly recognized clinically, and repeated isolations from patients on a hematology unit in Turku, Finland, led to an epidemiologic investigation. Isolates were recovered from multiple body sites of 23 patients (n = 180) from 1994 to 1995 and from 29 patients (n = 45) from 1997 to 2002; these plus 2 from the hospital kitchen were identified as S. cerevisiae. Isolates were genotyped by restriction fragment length polymorphism (RFLP) of genomic DNA after EcoR1… CONTINUE READING
BETA

Similar Papers

Figures, Tables, and Topics from this paper.

Explore Further: Topics Discussed in This Paper

References

Publications referenced by this paper.
SHOWING 1-10 OF 36 REFERENCES

Saccharomyces cerevisiae and the host-fungus interplay. In: Host-Fungal Interplay

KV Clemons, JH McCusker, RW Davis, DA Stevens
  • Vanden Bossche H, Stevens DA, Odds FC, Eds. Bethesda: National Foundation for Infectious Diseases,
  • 1997
VIEW 9 EXCERPTS
HIGHLY INFLUENTIAL

Saccharo - myces cerevisiae and the host - fungus interplay

KV Clemons, JH McCusker, RW Davis, DA Stevens
  • Host - Fungal Interplay
  • 1997
VIEW 6 EXCERPTS
HIGHLY INFLUENTIAL

Saccharomyces cerevisiae and the host-fungus interplay. In: Host-Fungal Interplay

KV Clemons, JH McCusker, RW Davis, DA Stevens
  • Vanden Bossche H, Stevens DA, Odds FC, Eds. Bethesda: National Foundation for Infectious Diseases,
  • 1997
VIEW 9 EXCERPTS
HIGHLY INFLUENTIAL

In vitro susceptibility testing and DNA typing of Saccharomyces cerevisiae clinical isolates

L Zerva, RJ Hollis, MA Pfaller
  • J Clin Microbiol
  • 1996
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

Saccharomyces cerevisiae fungemia: an adverse effect of Saccharomyces boulardii probiotic administration.

  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2005
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

Saccharomyces cerevisiae fungemia: an emerging infectious disease.

  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2005
VIEW 5 EXCERPTS
HIGHLY INFLUENTIAL